Rating History for Antares Pharma (ATRS) by Ladenburg Thalmann
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/14/2022 | Matthew Kaplan | Downgrade | Neutral (Buy) |
N/A (N/A) |
5.58 (5.59) |
0.18% | Details |
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/14/2022 | Matthew Kaplan | Downgrade | Neutral (Buy) |
N/A (N/A) |
5.58 (5.59) |
0.18% | Details |
![]() |
|||||||